Company Filing History:

15 out of 1,603

Sandoz Gmbh

Sandoz Pharmaceuticals Corp.

patents

Years Active: 1976-1990

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4939159 - Azaindole derivatives useful as cholesterol biosynthesis inhibitors (1990-07-03),

2. 4804679 - Erythro-(E)-7-(3'-C1-3alkyl-1'-(3',5'-dimethylphenyl)naphth-2'-yl (1989-02-14),

3. 4751235 - Anti-atherosclerotic indolizine derivatives (1988-06-14),

4. 4686237 - Erythro-(E)-7-[3'-C.sub.1-3 (1987-08-11),

5. 4359474 - 1-Phenyl-pyrazole derivatives as glucagon inhibitors (1982-11-16),

6. 4344966 - Anti-inflammatory 1-alkyl-1-phenyl-butanes (1982-08-17),

7. 4307113 - Anthranilic acid derivatives (1981-12-22),

8. 4220792 - 1-Phenyl-pyrazole derivatives (1980-09-02),

9. 4112117 - Alpha-cyano-o-anisidino derivatives (1978-09-05),

10. 4081476 - 1-Aryl-1-lower alkyl-1-buten-3-ols and ester derivatives (1978-03-28),

11. 4060638 - Anthranilic acid amides (1977-11-29),

12. 4051261 - 1-(P-Alkanoylphenyl) alkanols and derivatives (1977-09-27),

13. 4035406 - 4-ALKYL-4-NAPHTHYL-BUTANES (1977-07-12),

14. 4004009 - Antihypertensive aryl pyrazolo[4,3-c]pyridazinones (1977-01-18),

15. 3978057 - Substituted amino-hydrazinopyridazines (1976-08-31),

Title: Paul L Anderson: A Trailblazer in Inventions and Patents

Introduction:

Throughout his illustrious career, Paul L Anderson has become synonymous with innovation and inventive thinking. Hailing from Dover, NJ (US), Anderson's contributions have not only enhanced existing technologies but have also forged new paths in numerous industries. His commendable commitment to excellence and his ability to think outside the box have led to numerous milestones and well-deserved accolades.

Latest Patents:

Anderson's insatiable thirst for pushing boundaries is epitomized by his latest patents, which include the following groundbreaking inventions:

1. Azaindole derivatives useful as cholesterol biosynthesis inhibitors:

Anderson's invention represents a crucial development in the field of cholesterol biosynthesis. These compounds possess a unique formula, with X denoting an unsubstituted 6-membered aromatic ring containing three carbon atoms and one nitrogen atom. By inhibiting cholesterol biosynthesis, these derivatives offer potential advancements in the treatment of various related disorders.

2. Erythro-(E)-7-(3'-C1-3alkyl-1'-(3',5'-dimethylphenyl)naphth-2'-yl:

This compound, developed by Anderson, holds immense value in the realm of therapeutic research. Designed with R.sub.1 representing C.sub.1-3 alkyl, this invention opens up exciting possibilities for novel therapies and advancements in various industries.

Career Highlights:

Anderson's career boasts an impressive array of notable achievements and contributions. His continuous pursuit of excellence has garnered recognition both within the scientific community and beyond. Through his inventive work, he has significantly impacted several industries, constantly pushing the boundaries of what is possible.

Collaborations:

Throughout his career, Anderson has collaborated with some influential figures, reinforcing his commitment to knowledge exchange and collective growth. Noteworthy individuals he has worked alongside include Darryl A Brittain and Nicholas A Paolella, who have all brought diverse expertise to their collaborations. Their collaborative efforts exemplify the power of teamwork in driving innovation forward.

Conclusion:

Paul L Anderson's legacy as an inventor and patent holder is firmly established. His relentless pursuit of groundbreaking ideas and his ability to transform them into tangible inventions have opened up new avenues of possibilities for various industries. Through his commendable career, Anderson has set an example for future inventors, emphasizing the importance of creativity, perseverance, and collaboration in the field of innovations and patents.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com